Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$604K Hold
11,317
0.77% 40
2022
Q3
$506K Hold
11,317
0.52% 42
2022
Q2
$581K Hold
11,317
0.56% 42
2022
Q1
$591K Hold
11,317
0.47% 45
2021
Q4
$678K Hold
11,317
0.48% 43
2021
Q3
$622K Sell
11,317
-23,576
-68% -$1.31M 0.48% 42
2021
Q2
$1.79M Buy
34,893
+5,658
+19% +$292K 1.27% 25
2021
Q1
$1.5M Buy
29,235
+17,918
+158% +$984K 1.22% 24
2020
Q4
$613K Buy
+11,317
New +$604K 0.54% 45

Other funds holding QGEN

swisspartners's QGEN Position: Q4 2022 in Review

swisspartners held its Qiagen (QGEN) position steady in Q4 2022 at 11,317 shares worth $604K. The position accounts for 0.77% of the portfolio, ranked #40.

swisspartners first reported a position in QGEN in Q4 2020 and has held it in 9 quarters since. The position peaked at $1.79M in Q2 2021. 297 funds tracked by Wall St. Rank hold QGEN as of Q4 2022.

  • swisspartners held 11,317 shares of Qiagen worth $604K as of Q4 2022.
  • swisspartners left its Qiagen share count unchanged in Q4 2022.
  • Qiagen made up 0.77% of swisspartners's portfolio in Q4 2022, its #40 holding.
  • swisspartners first reported a position in Qiagen in Q4 2020 and has held it in 9 quarters since.
  • swisspartners's Qiagen position peaked at $1.79M in Q2 2021.
  • 297 funds tracked by Wall St. Rank held Qiagen as of Q4 2022.

Based on swisspartners's 13F filing for Q4 2022, filed 14 Feb 2023.